Cyproterone Acetate in the Treatment of Advanced Carcinoma of the Prostate

Robert B. Smith; Patrick C. Walsh; Willard E. Goodwin

doi:10.1016/s0022-5347(17)60128-9

Back to search

Cyproterone Acetate in the Treatment of Advanced Carcinoma of the Prostate

Robert B. Smith, Patrick C. Walsh, Willard E. Goodwin

DOI: 10.1016/s0022-5347(17)60128-9

The Journal of Urology

Data up to Jan 2025

Published1973

Citations74

References8

Fields

Medicine Urology Gynecology Internal medicine

Total Citations Per Year

Abstract

References (8)

Receptor Proteins for Androgens

1969 • 452 citations

Aspects of Androgen-Dependent Events as Studied by Antiandrogens

1970 • 270 citations

Medical Treatment of Benign Nodular Prostatic Hyperplasia with Cyproterone Acetate

1969 • 134 citations

A new oral progestational steroid effective in treating prostatic cancer.

1966 • 55 citations

Mechanism of Androgenic Action: Effect of Specific Intracellular Inhibitors

1971 • 40 citations

Effects of an Anti-androgen, SH 714 (6-Chlor Δ⁶-l, 2α- Methylen-17α-hydroxyprogesterone Acetate, Cyproterone Acetate) on Canine Prostatic Hyperplasia¹

1968 • 26 citations

Effect of progestational agents on carcinoma of the prostate.

1967 • 23 citations

A NEW ANTIANDROGEN, SH-714.

1964 • 13 citations

Cited By (0)

No citing papers found in database